67 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
6 Jun 24
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
2:57pm
extending patient survival and establishing a new standard of care for cancer.
“We remain steadfast in our goals for responsible access to capital. We … have increased our access to cash while keeping dilution to a minimum. We plan to continue this strategy, which has shown desired outcomes so far
8-K
EX-99.2
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
security access our or related financial instrument or to participate in any trading strategy. The summary may include “forward-looking statements
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
3 Jun 24
Regulation FD Disclosure
4:05pm
: tjankowski.onkolog@wp.pl) Scan QR Code to access our presentation and a digital version of the poster Figure 1. THIO-101 study schema Figure 4. Patients receiving
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance … use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii
8-K
EX-10.1
tqaw3f6ncqe752y2bl1r
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
rdv62
13 Mar 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-99.1
85dkdfw7sxt43mnou
6 Mar 24
Other Events
8:00am
424B5
o6hohb5u76i vz
14 Feb 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-1.1
jm5tvb5zwx1iks97
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
0x4d5wcjq y4l
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
424B5
x9mhoninga3knuz
17 Nov 23
Prospectus supplement for primary offering
9:06am
8-K
EX-10.1
k2cdskikjm ho1
15 Nov 23
Termination of a Material Definitive Agreement
8:42am
8-K
EX-10.1
t4cgmkmgz5fn4p2zun
1 Sep 23
Entry into a Material Definitive Agreement
4:45pm
424B5
h7fyay6wrpxkkh
1 Sep 23
Prospectus supplement for primary offering
4:30pm
S-3
nfg tnl0lu1ip63b3e36
14 Aug 23
Shelf registration
6:05pm
FWP
nw9vcsfhd7jgvs7i64
11 Jul 23
Free writing prospectus
12:42pm
FWP
2zofwsj4 06
9 Jun 23
Free writing prospectus
6:47am